(S (NP (NP (DT The) (JJ lethal) (NN nature)) (PP (IN of) (NP (JJ pancreatic) (JJ ductal) (NN adenocarcinoma))) (PRN (-LRB- -LRB-) (NP (NN PDAC)) (-RRB- -RRB-))) (VP (VBZ calls) (PP (IN for) (NP (NP (JJ early) (JJ differential) (NN diagnosis)) (PP (IN of) (NP (JJ pancreatic) (NNS cysts))))) (, ,) (SBAR (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN identified) (PP (IN in) (NP (NP (QP (RB up) (IN to) (CD 16)) (NN %)) (PP (IN of) (NP (JJ normal) (NNS subjects))))))))) (, ,) (CC and) (SBAR (WHNP (NP (DT some)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (MD may) (VP (VB develop) (PP (IN into) (NP (NN PDAC))))))))) (. .))
(S (NP (JJ Previous) (ADJP (NN computer) (HYPH -) (VBN aided)) (NNS developments)) (VP (VBP have) (VP (VBN achieved) (NP (NP (JJ certain) (NN accuracy)) (PP (IN for) (NP (NN classification)))) (PP (IN on) (NP (NP (JJ segmented) (JJ cystic) (NNS lesions)) (PP (IN in) (NP (NNP CT.))))))) (. .))
(S (ADVP (RB However)) (, ,) (S (NP (JJ pancreatic) (NNS cysts)) (VP (VBP have) (NP (NP (DT a) (JJ large) (NN variation)) (PP (IN in) (NP (NN size) (CC and) (NN shape)))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ precise) (NN segmentation)) (PP (IN of) (NP (PRP them)))) (VP (VBZ remains) (ADJP (RB rather) (JJ challenging)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ restricts) (NP (NP (DT the) (ADJP (NN computer) (HYPH -) (VBN aided)) (NN interpretation)) (PP (IN of) (NP (NP (NN CT) (NNS images)) (VP (VBN acquired) (PP (IN for) (NP (JJ differential) (NN diagnosis)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP propose) (NP (NP (DT a) (ADJP (NN computer) (HYPH -) (VBN aided)) (NN framework)) (PP (IN for) (NP (NP (JJ early) (JJ differential) (NN diagnosis)) (PP (IN of) (NP (JJ pancreatic) (NNS cysts)))))) (PP (IN without) (S (VP (VBG pre-segmenting) (NP (DT the) (NNS lesions)) (S (VP (VBG using) (NP (ADJP (RB densely) (HYPH -) (VBN connected)) (JJ convolutional) (NNS networks) (PRN (-LRB- -LRB-) (NP (JJ Dense) (HYPH -) (NN Net)) (-RRB- -RRB-))))))))) (. .))
(S (NP (DT The) (JJ Dense) (HYPH -) (NN Net)) (VP (VP (VBZ learns) (NP (NML (JJ high) (HYPH -) (NN level)) (NNS features)) (PP (IN from) (NP (JJ whole) (JJ abnormal) (NN pancreas)))) (CC and) (VP (VBZ builds) (NP (NP (NNS mappings)) (PP (IN between) (NP (NML (JJ medical) (NN imaging)) (NN appearance)))) (PP (IN to) (NP (NP (JJ different) (JJ pathological) (NNS types)) (PP (IN of) (NP (JJ pancreatic) (NNS cysts))))))) (. .))
(S (S (VP (TO To) (VP (VB enhance) (NP (DT the) (JJ clinical) (NN applicability))))) (, ,) (NP (PRP we)) (VP (VBP integrate) (NP (NN saliency) (NNS maps)) (PP (IN in) (NP (DT the) (NN framework) (S (VP (TO to) (VP (VB assist) (NP (DT the) (NNS physicians)) (S (VP (TO to) (VP (VB understand) (NP (NP (DT the) (NN decision)) (PP (IN of) (NP (DT the) (NML (JJ deep) (NN learning)) (NN method))))))))))))) (. .))
(S (NP (NP (DT The) (NN test)) (PP (IN on) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (NP (CD 206) (NNS patients)) (PP (IN with) (ADVP (NP (CD 4)) (RB pathologically)))))))) (VP (VBD confirmed) (SBAR (S (NP (NP (NNS subtypes)) (PP (IN of) (NP (JJ pancreatic) (NNS cysts)))) (VP (VBZ has) (VP (VBN achieved) (NP (NP (DT an) (JJ overall) (NN accuracy)) (PP (IN of) (NP (NP (CD 72.8) (NN %)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN than) (NP (NP (DT the) (NN baseline) (NN accuracy)) (PP (IN of) (NP (NP (CD 48.1) (NN %)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB strongly)) (VP (VBZ supports) (NP (NP (DT the) (JJ clinical) (NN potential)) (PP (IN of) (NP (PRP$ our) (JJ developed) (NN method))))))))))))))))))))))) (. .))
